21 CFR 864.7415 — Hemoglobin S

Hematology (HE) · Part 864 Subpart H—Hematology Kits and Packages · § 864.7415

Identification

An abnormal hemoglobin assay is a device consisting of the reagents, apparatus, instrumentation, and controls necessary to isolate and identify abnormal genetically determined hemoglobin types.

Classification Rationale

Class II (special controls). A control intended for use with an abnormal hemoglobin assay is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

Product Codes

Product CodeDevice NameClassDevicesAttributes
GIQHemoglobin S233rd Party
GKAAbnormal Hemoglobin Quantitation2233rd Party
JCMControl, Hemoglobin, Abnormal212
JPBHemoglobin M203rd Party
MLLHemoglobin C (Abnormal Hemoglobin Variant)213rd Party

Special Controls

GIQ — Hemoglobin S

*Classification.* Class II (special controls). A control intended for use with an abnormal hemoglobin assay is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

eCFR

GKA — Abnormal Hemoglobin Quantitation

*Classification.* Class II (special controls). A control intended for use with an abnormal hemoglobin assay is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

eCFR

JCM — Control, Hemoglobin, Abnormal

*Classification.* Class II (special controls). A control intended for use with an abnormal hemoglobin assay is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

eCFR

JPB — Hemoglobin M

*Classification.* Class II (special controls). A control intended for use with an abnormal hemoglobin assay is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

eCFR

MLL — Hemoglobin C (Abnormal Hemoglobin Variant)

*Classification.* Class II (special controls). A control intended for use with an abnormal hemoglobin assay is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.

eCFR

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...